-+ 0.00%
-+ 0.00%
-+ 0.00%

Leerink Partners Initiates Coverage On Altimmune with Outperform Rating, Announces Price Target of $10

Benzinga·06/22/2026 14:41:38
Listen to the news
Leerink Partners analyst Thomas Smith initiates coverage on Altimmune (NASDAQ:ALT) with a Outperform rating and announces Price Target of $10.